The United States Food and Drug Administration (FDA) has granted an expanded regulatory approval for Eli Lilly and Company’s Jaypirca,…
Read More
Pioneering Optogenetics Research Earns 2026 Nobel Prize in Physiology or Medicine and Ushers in a New Frontier for Ophthalmology
The 2026 Nobel Prize in Physiology or Medicine has been awarded to a distinguished trio of researchers—Karl Deisseroth of Stanford…
Read More
Navigating the Challenge of GLP-1RA Non-Responders in Obesity and Metabolic Disease Management
The rapid global adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has fundamentally transformed the therapeutic landscape for obesity and type…
Read More
EASD 2026: Tirzepatide Outperforms Semaglutide in Real-World Type 2 Diabetes Analysis
The landscape of metabolic disease management continues to undergo a profound transformation as comparative clinical data accumulates for the newest…
Read More
BioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery Collaboration
In a significant move bridging artificial intelligence and biotechnology, BioMarin Pharmaceutical has forged a strategic research collaboration with Emeryville-based tech…
Read More
Pharma commercial vendor selection still runs on word of mouth. A Harvard MBA student aims to change that with Rx Almanac.
For pharmaceutical companies navigating the complex transition from clinical success to commercial launch, the process of selecting service providers—ranging from…
Read More
FDA Expands Approval of Bristol Myers Squibb’s Camzyos to Treat Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
The United States Food and Drug Administration (FDA) has officially expanded the approved indication for Bristol Myers Squibb’s (BMS) flagship…
Read More
Varda Space Industries Secures $251m in Series D Funding to Pioneer Commercial In-Space Pharmaceutical Manufacturing
Varda Space Industries has successfully closed a massive $251m Series D financing round, bringing its cumulative venture backing to $598m…
Read More
As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%
The pharmaceutical and biotechnology sectors, which endured a protracted period of aggressive workforce contraction beginning in 2022, are beginning to…
Read More
Navigating Complexity: Inside the Core Drivers, Sustainable Shifts, and Cold Chain Revolutions Shaping the Future of Global Pharma
The contemporary pharmaceutical landscape exists in a perpetual state of high-velocity transformation, pulled in multiple directions by technological innovation, complex…
Read More
